SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosisTopline data expected in ...

600 mg once daily bexobrutideg oral dose cleared by global regulators for pivotal monotherapy trials in relapsed/refractory chronic lymphocytic ...

ThinkEquity will make its rule 10b-18 purchases (as defined in Rule 10b-18 of the Securities Exchange Act of 1934) in ...

Ultimately, effective partnering defines how we treat people as we design and build projects. By inviting the broadest group ...

Detailed price information for Santacruz Silver Mining Ltd (SCZ-X) from The Globe and Mail including charting and trades.

Let's explore the zodiac sign of Aries with this fun fiery flow focusing on inner power. Join the 30-Day Yoga & Pilates ...

As Dallas City Hall’s future hangs in the balance with mounting maintenance issues, the site in the southern half of downtown ...

When Reserve Bank of India (RBI) directed banks to initiate insolvency proceedings against the country’s largest corporate ...

SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an ESMO Data Update and Third Quarter ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that a global licensing and collaboration agreement with Novartis, previously announced on September 2, 2025, has now closed. Closing of ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys”) and SpayVac for Wildlife, Inc. are pleased to announce that ...